cetylpyridinium chloride anhydrous has been researched along with pulmicort in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Behrend, EN; Kemppainen, RJ; Smith-Carr, S; Stroup, ST | 1 |
Celedón, JC; Cohen, RT; Fuhlbrigge, AL; Raby, BA; Rosner, BA; Strunk, RC; Van Steen, K; Weiss, ST; Zeiger, RS | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and pulmicort
Article | Year |
---|---|
In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Asthma; Budesonide; Child; Child, Preschool; Female; Functional Residual Capacity; Health; Humans; Longitudinal Studies; Male; Pregnancy; Prenatal Exposure Delayed Effects; Time Factors; Tobacco Smoke Pollution; Treatment Outcome | 2010 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and pulmicort
Article | Year |
---|---|
Effects of oral administration of controlled-ileal-release budesonide and assessment of pituitary-adrenocortical axis suppression in clinically normal dogs.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Budesonide; Delayed-Action Preparations; Dogs; Health; Hydrocortisone; Ileum; Male; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System | 2006 |